|
1
|
Chuaysri C, Thuwajit P, Paupairoj A,
Chau-In S, Suthiphongchai T and Thuwajit C: Alpha-smooth muscle
actin-positive fibroblasts promote biliary cell proliferation and
correlate with poor survival in cholangiocarcinoma. Oncol Rep.
21:957–969. 2009.PubMed/NCBI
|
|
2
|
Nakagohri T, Kinoshita T, Konishi M,
Takahashi S and Gotohda N: Surgical outcome and prognostic factors
in intrahepatic cholangiocarcinoma. World J Surg. 32:2675–2680.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Utispan K, Thuwajit P, Abiko Y, Charngkaew
K, Paupairoj A, Chau-in S and Thuwajit C: Gene expression profiling
of cholangiocarcinoma-derived fibroblast reveals alterations
related to tumor progression and indicates periostin as a poor
prognostic marker. Mol Cancer. 9:132010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillan L, Matei D, Fishman DA, Gerbin CS,
Karlan BY and Chang DD: Periostin secreted by epithelial ovarian
carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5)
integrins and promotes cell motility. Cancer Res. 62:5358–5364.
2002.PubMed/NCBI
|
|
5
|
Puglisi F, Puppin C, Pegolo E, Andreetta
C, Pascoletti G, D'Aurizio F, Pandolfi M, Fasola G, Piga A, Damante
G and Di Loreto C: Expression of periostin in human breast cancer.
J Clin Pathol. 61:494–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kudo Y, Ogawa I, Kitajima S, Kitagawa M,
Kawai H, Gaffney PM, Miyauchi M and Takata T: Periostin promotes
invasion and anchorage-independent growth in the metastatic process
of head and neck cancer. Cancer Res. 66:6928–6935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ben QW, Jin XL, Liu J, Cai X, Yuan F and
Yuan YZ: Periostin, a matrix specific protein, is associated with
proliferation and invasion of pancreatic cancer. Oncol Rep.
25:709–716. 2011.PubMed/NCBI
|
|
10
|
Utispan K, Sonongbua J, Thuwajit P,
Chau-In S, Pairojkul C, Wongkham S and Thuwajit C: Periostin
activates integrin α5β1 through a PI3K/AKT-dependent pathway in
invasion of cholangiocarcinoma. Int J Oncol. 41:1110–1118. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mino M, Kanno K, Okimoto K, Sugiyama A,
Kishikawa N, Kobayashi T, Ono J, Izuhara K, Kobayashi T, Ohigashi
T, et al: Periostin promotes malignant potential by induction of
epithelial-mesenchymal transition in intrahepatic
cholangiocarcinoma. Hepatol Commun. 1:1099–1109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cervantes-Arias A, Pang LY and Argyle DJ:
Epithelial-mesenchymal transition as a fundamental mechanism
underlying the cancer phenotype. Vet Comp Oncol. 11:169–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu W, Yang Z and Lu N: A new role for the
PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adhes Migr. 9:317–324. 2015. View Article : Google Scholar
|
|
14
|
Son H and Moon A: Epithelial-mesenchymal
transition and cell invasion. Toxicol Res. 26:245–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song L, Wang P, Tian Y, Chang D, Li K, Fan
Y, Shen J, Du H, Mi R, Bian X and Tang X: Lung metastasis of
pancreatic carcinoma is regulated by TGFβ signaling. Tumour Biol.
36:2271–2276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yue B, Ren QX, Su T, Wang LN and Zhang L:
ERK5 silencing inhibits invasion of human osteosarcoma cell via
modulating the Slug/MMP-9 pathway. Eur Rev Med Pharmacol Sci.
18:2640–2647. 2014.PubMed/NCBI
|
|
18
|
Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu
L, Tang X, Du YE, Hu P and Liu M: Twist induces
epithelial-mesenchymal transition and cell motility in breast
cancer via ITGB1-FAK/ILK signaling axis and its associated
downstream network. Int J Biochem Cell Biol. 71:62–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li ZH, Zhou Y, Ding YX, Guo QL and Zhao L:
Roles of integrin in tumor development and the target inhibitors.
Chin J Nat Med. 17:241–251. 2019.PubMed/NCBI
|
|
21
|
Menakongka A and Suthiphongchai T:
Involvement of PI3K and ERK1/2 pathways in hepatocyte growth
factor-induced cholangiocarcinoma cell invasion. World J
Gastroenterol. 16:713–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato Y, Harada K, Itatsu K, Ikeda H,
Kakuda Y, Shimomura S, Shan Ren X, Yoneda N, Sasaki M and Nakanuma
Y: Epithelial-mesenchymal transition induced by transforming growth
factor-{beta}1/Snail activation aggravates invasive growth of
cholangiocarcinoma. Am J Pathol. 177:141–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Techasen A, Namwat N, Loilome W,
Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H and
Yongvanit P: Tumor necrosis factor-α (TNF-α) stimulates the
epithelial-mesenchymal transition regulator Snail in
cholangiocarcinoma. Med Oncol. 29:3083–3091. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vaquero J, Guedj N, Clapéron A, Nguyen
Ho-Bouldoires TH, Paradis V and Fouassier L: Epithelial-mesenchymal
transition in cholangiocarcinoma: From clinical evidence to
regulatory networks. J Hepatol. 66:424–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu WW, Chen PC, Chen JM, Wu YM, Liu PY, Lu
CH, Lin YF, Tang CH and Chao CC: Periostin promotes
epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung
cancer. Oncotarget. 8:62248–62260. 2017.PubMed/NCBI
|
|
26
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ryu HS, Chung JH, Lee K, Shin E, Jing J,
Choe G, Kim H, Xu X, Lee HE, Kim DG, et al: Overexpression of
epithelial-mesenchymal transition-related markers according to cell
dedifferentiation: Clinical implications as an independent
predictor of poor prognosis in cholangiocarcinoma. Hum Pathol.
43:2360–2370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Zohar R and McCulloch CA: Multiple
roles of alpha-smooth muscle actin in mechanotransduction. Exp Cell
Res. 312:205–214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ivaska J, Pallari HM, Nevo J and Eriksson
JE: Novel functions of vimentin in cell adhesion, migration, and
signaling. Exp Cell Res. 313:2050–2062. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leggett SE, Sim JY, Rubins JE, Neronha ZJ,
Williams EK and Wong IY: Morphological single cell profiling of the
epithelial-mesenchymal transition. Integr Biol. 8:1133–1144. 2016.
View Article : Google Scholar
|
|
32
|
İnce AT, Yıldız K, Gangarapu V, Kayar Y,
Baysal B, Karatepe O, Kemik AS and Şentürk H: Serum and biliary
MMP-9 and TIMP-1 concentrations in the diagnosis of
cholangiocarcinoma. Int J Clin Exp Med. 8:2734–2740.
2015.PubMed/NCBI
|
|
33
|
Sun Q, Zhao C, Xia L, He Z, Lu Z, Liu C,
Jia M, Wang J and Niu J: High expression of matrix
metalloproteinase-9 indicates poor prognosis in human hilar
cholangiocarcinoma. Int J Clin Exp Pathol. 7:6157–6164.
2014.PubMed/NCBI
|
|
34
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Watanabe A, Suzuki H, Yokobori T, Altan B,
Kubo N, Araki K, Wada S, Mochida Y, Sasaki S, Kashiwabara K, et al:
Forkhead box protein C2 contributes to invasion and metastasis of
extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
Cancer Sci. 104:1427–1432. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Wang W, Wang W, Yang R, Wang T, Su
T, Weng D, Tao T, Li W, Ma D and Wang S: Correlation of TWIST2
up-regulation and epithelial-mesenchymal transition during
tumorigenesis and progression of cervical carcinoma. Gynecol Oncol.
124:112–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mao Y, Zhang N, Xu J, Ding Z, Zong R and
Liu Z: Significance of heterogeneous Twist2 expression in human
breast cancers. PLoS One. 7:e481782012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nitta T, Mitsuhashi T, Hatanaka Y,
Miyamoto M, Oba K, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S
and Matsuno Y: Prognostic significance of epithelial-mesenchymal
transition-related markers in extrahepatic cholangiocarcinoma:
Comprehensive immunohistochemical study using a tissue microarray.
Br J Cancer. 111:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
